[HTML][HTML] Cardiac fibrosis in the pressure overloaded left and right ventricle as a therapeutic target
K Schimmel, K Ichimura, S Reddy, F Haddad… - Frontiers in …, 2022 - frontiersin.org
Myocardial fibrosis is a remodeling process of the extracellular matrix (ECM) following
cardiac stress.“Replacement fibrosis” is a term used to describe wound healing in the acute …
cardiac stress.“Replacement fibrosis” is a term used to describe wound healing in the acute …
Right ventricular fibrosis and dysfunction: Actual concepts and common misconceptions
B Egemnazarov, S Crnkovic, BM Nagy, H Olschewski… - Matrix Biology, 2018 - Elsevier
Fibrosis and remodeling of the right ventricle (RV) are associated with RV dysfunction and
mortality of patients with pulmonary hypertension (PH) but it is unknown how much RV …
mortality of patients with pulmonary hypertension (PH) but it is unknown how much RV …
Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension
R Savai, HM Al-Tamari, D Sedding, B Kojonazarov… - Nature medicine, 2014 - nature.com
Pulmonary hypertension (PH) is characterized by increased proliferation and apoptosis
resistance of pulmonary artery smooth muscle cells (PASMCs). Forkhead box O (FoxO) …
resistance of pulmonary artery smooth muscle cells (PASMCs). Forkhead box O (FoxO) …
Cardiovascular safety of tyrosine kinase inhibitors: with a special focus on cardiac repolarisation (QT interval)
RR Shah, J Morganroth, DR Shah - Drug safety, 2013 - Springer
The development of tyrosine kinase inhibitors (TKI) represents a major milestone in
oncology. However, their use has been found to be associated with serious toxicities that …
oncology. However, their use has been found to be associated with serious toxicities that …
[HTML][HTML] Translational Advances in the Field of Pulmonary Hypertension.From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting …
Pulmonary arterial hypertension (PAH) has been frequently compared with a type of
malignant disease and has an incredible number of pathogenic mechanisms similar to …
malignant disease and has an incredible number of pathogenic mechanisms similar to …
Mitochondrial complex IV subunit 4 isoform 2 is essential for acute pulmonary oxygen sensing
N Sommer, M Hüttemann, O Pak, S Scheibe… - Circulation …, 2017 - Am Heart Assoc
Rationale: Acute pulmonary oxygen sensing is essential to avoid life-threatening hypoxemia
via hypoxic pulmonary vasoconstriction (HPV) which matches perfusion to ventilation …
via hypoxic pulmonary vasoconstriction (HPV) which matches perfusion to ventilation …
[HTML][HTML] Molecular mechanisms and targets of right ventricular fibrosis in pulmonary hypertension
FT Bekedam, MJ Goumans, HJ Bogaard… - Pharmacology & …, 2023 - Elsevier
Right ventricular fibrosis is a stress response, predominantly mediated by cardiac
fibroblasts. This cell population is sensitive to increased levels of pro-inflammatory …
fibroblasts. This cell population is sensitive to increased levels of pro-inflammatory …
Right heart failure in pulmonary hypertension: diagnosis and new perspectives on vascular and direct right ventricular treatment
K Tello, W Seeger, R Naeije… - British journal of …, 2021 - Wiley Online Library
Adaptation of right ventricular (RV) function to increased afterload—known as RV–arterial
coupling—is a key determinant of prognosis in pulmonary hypertension. However …
coupling—is a key determinant of prognosis in pulmonary hypertension. However …
[HTML][HTML] Maternal and perinatal obesity induce bronchial obstruction and pulmonary hypertension via IL-6-FoxO1-axis in later life
Obesity is a pre-disposing condition for chronic obstructive pulmonary disease, asthma, and
pulmonary arterial hypertension. Accumulating evidence suggests that metabolic influences …
pulmonary arterial hypertension. Accumulating evidence suggests that metabolic influences …
[HTML][HTML] Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension
A Alzoubi, M Toba, K Abe, KD O'Neill… - American Journal …, 2013 - journals.physiology.org
Current therapy of pulmonary arterial hypertension (PAH) is inadequate.
Dehydroepiandrosterone (DHEA) effectively treats experimental pulmonary hypertension in …
Dehydroepiandrosterone (DHEA) effectively treats experimental pulmonary hypertension in …